It is literally that much of a moving feast with MSB and all of its ongoing programs.
I have said it before, but truly, we are dealing with a "Black Swan" company here. I am no great resource on the topic, but I challenge anyone to name one company with SO MANY blockbusters in the pipeline that are all due to pop within the space of, say, 1 year from the date of our likely first FDA approval (assuming we use that measure as the gauge).
It's like Apple coming out with the iPod, the iMac, the Apple Watch, and the iPhone, all in the space of 12 months.
MSB - one of a kind.
Ann: ODAC Votes in Favor of Remestemcel-L for GvHD, page-125
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |